Related Experiment Video
Updated: Jul 19, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Overexpression of the mTOR alpha4 phosphoprotein activates protein phosphatase 2A and increases Stat1alpha binding to
Wei Lun Nien1, Shauna M Dauphinee, Lori D Moffat
1Department of Biochemistry & Molecular Biology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 1X5, Canada.
Abstract:
Alpha4 phosphoprotein in the mTOR pathway is a prolactin (PRL)-downregulated gene product that interacts with the catalytic subunit of serine/threonine protein phosphatase 2A (PP2Ac) in rat Nb2 lymphoma cells. Transient overexpression of alpha4 in COS-1 cells inhibited PRL-inducible interferon-regulatory-1 (IRF-1) promoter activity, but the mechanism underlying this inhibition was not known. The present study showed a stable alpha4-PP2Ac complex that was not dissociated by rapamycin in COS-1 cells. Transient overexpression of alpha4 in COS-1 cells had no effect on endogenous PP2Ac protein levels but significantly increased PP2Ac carboxymethylation and PP2A activity as compared to controls. The increased PP2A activity was accompanied by decreased phosphorylation of eukaryotic initiation factor 4E-binding protein (4E-BP1) but had no effect on Stat phosphorylation. However, overexpressed alpha4 decreased arginine methylation of Stat1alpha and increased Stat1alpha binding to the Stat1alpha-specific inhibitor, PIAS1. In summary, ectopic alpha4 increased PP2A activity in COS-1 cells and this was accompanied by Stat1alpha hypomethylation and increased Stat1alpha-PIAS1 association. These events would inhibit Stat action and ultimately inhibit PRL-inducible IRF-1 promoter activity.
Insights
Alpha4 phosphoprotein enhances protein phosphatase 2A (PP2A) activity by increasing its carboxymethylation. This leads to decreased Stat1alpha methylation and increased Stat1alpha-PIAS1 association, ultimately inhibiting prolactin-induced IRF-1 promoter activity.
Area of Science:
- Cellular signaling pathways
- Protein-protein interactions
- Gene regulation
Background:
- Alpha4 phosphoprotein is a prolactin (PRL)-downregulated gene product.
- Alpha4 interacts with protein phosphatase 2A catalytic subunit (PP2Ac).
- Alpha4 overexpression inhibits PRL-inducible IRF-1 promoter activity via an unknown mechanism.
Purpose of the Study:
- To elucidate the mechanism by which alpha4 inhibits PRL-inducible IRF-1 promoter activity.
- To investigate the interaction between alpha4 and PP2Ac.
- To determine the effect of alpha4 on PP2A activity and downstream signaling.
Main Methods:
- Stable alpha4-PP2Ac complex formation was assessed in COS-1 cells.
- PP2Ac carboxymethylation and PP2A activity were measured following alpha4 overexpression.
- Phosphorylation of eukaryotic initiation factor 4E-binding protein (4E-BP1) and Stat was analyzed.
- Arginine methylation of Stat1alpha and its association with PIAS1 were evaluated.
Main Results:
- A stable alpha4-PP2Ac complex was observed, unaffected by rapamycin.
- Alpha4 overexpression increased PP2Ac carboxymethylation and PP2A activity.
- Increased PP2A activity correlated with decreased 4E-BP1 phosphorylation.
- Alpha4 overexpression led to Stat1alpha hypomethylation and increased Stat1alpha-PIAS1 binding.
Conclusions:
- Ectopic alpha4 enhances PP2A activity in COS-1 cells.
- Alpha4-mediated PP2A activation results in Stat1alpha hypomethylation and increased association with PIAS1.
- These molecular events contribute to the inhibition of Stat-mediated transcription and PRL-inducible IRF-1 promoter activity.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
